Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0UH4T
|
||||
| Former ID |
DCL000832
|
||||
| Drug Name |
GW-493838
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Discontinued in Phase 2 | [1] | ||
| Therapeutic Class |
Analgesics
|
||||
| Company |
GlaxoSmithKline
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H25ClFN7O4
|
||||
| Canonical SMILES |
CC(C)(C)C1=NN=C(O1)CC2C(C(C(O2)N3C=NC4C3N=CN=C4NC5=C(C=<br />C(C=C5)Cl)F)O)O
|
||||
| InChI |
1S/C22H25ClFN7O4/c1-22(2,3)21-30-29-14(35-21)7-13-16(32)17(33)20(34-13)31-9-27-15-18(25-8-26-19(15)31)28-12-5-4-10(23)6-11(12)24/h4-6,8-9,13,15-17,19-20,32-33H,7H2,1-3H3,(H,25,26,28)
|
||||
| InChIKey |
HWYPWMWKJGSTFH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A1 receptor | Target Info | Modulator | [2] | |
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addiction | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| RANKL Signaling Pathway | |||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Reactome | Adenosine P1 receptors | ||||
| G alpha (i) signalling events | |||||
| WikiPathways | Nucleotide GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. | ||||
| REF 2 | A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opin Investig Drugs. 2008 Dec;17(12):1901-10. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.